\-\ Texto\\:\\ \ \(0\)\
\-\ multiple\\ erythematous\\ nodules\\,\\ some\\ with\\ superficial\\ ulceration\\,\\ and\\ plaques\\ distributed\\ over\\ hands\\,\\ wrists\\,\\ forearms\\,\\ bilateral\\ lower\\ extremities\\,\\ and\\ feet\\.\\ hyperpigmented\\ plaques\\ on\\ scalp\\.\ \(0\)\
\-\ heme\\/onc\\ administered\\ 6\\ cycles\\ of\\ chop\\ chemotherapy\\ with\\ clinical\\ remission\\ of\\ the\\ nodules\\.\\ biopsy\\ was\\ performed\\ at\\ three\\ previously\\ involved\\ sites\\,\\ which\\ revealed\\ an\\ atypical\\ t\\-cell\\ lymphoid\\ infiltrate\\ felt\\ to\\ represent\\ residual\\ t\\-cell\\ lymphoma\\.\\ total\\ skin\\ electron\\ beam\\ \\(tseb\\)\\ therapy\\ was\\ administered\\ for\\ 9\\ weeks\\.\\ the\\ patient\\ had\\ clinical\\ remission\\ of\\ all\\ active\\ lesions\\.\\ follow\\ up\\ was\\ scheduled\\ for\\ 3\\ months\\ after\\ completing\\ tseb\\.\ \(0\)\
\-\ plaques\\ and\\ nodules\\ with\\ superficial\\ ulceration\\ on\\ bilateral\\ lower\\ extremities\\.\ \(0\)\
\-\ cutaneous\\ t\\-cell\\ lymphoma\\ \\(case\\ 1\\,\\ 25th\\ annual\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ san\\ antonio\\,\\ tx\\)\ \(0\)\
\-\ mycosis\\ fungoides\\(guttate\\ dermatosis\\)\\ \ \(0\)\
\-\ pityriasis\\ rosea\\ \ \(0\)\
\-\ eczema\ \(6\)\
\-\ neurodermatitis\ \(0\)\
\-\ pseudolymphoma\\ syndrome\ \(0\)\
\-\ diagnosed\\ with\\ mycosis\\ fungoides\\ in\\ april\\ 1997\\.\\ now\\ presenting\\ in\\ june\\ 1998\\ with\\ plaques\\ on\\ lower\\ extremities\\ and\\ face\\ recalcitrant\\ to\\ treatment\\ with\\ topical\\ nitrogen\\ mustard\\ and\\ corticosteroids\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ plaques\\:\\ 0\\.3050415996579643\ \(0\)\
\-\ tseb\\:\\ 0\\.24175845066809099\ \(0\)\
\-\ fungoides\\:\\ 0\\.2233891629066502\ \(0\)\
\-\ mycosis\\:\\ 0\\.21747557309317184\ \(0\)\
\-\ remission\\:\\ 0\\.18352918613441155\ \(0\)\
\-\ nodules\\:\\ 0\\.18017411283798646\ \(0\)\
\-\ extremities\\:\\ 0\\.17232568467085346\ \(0\)\
\-\ ulceration\\:\\ 0\\.1651598983729708\ \(0\)\
\-\ administered\\:\\ 0\\.1564541199953711\ \(0\)\
\-\ superficial\\:\\ 0\\.14606450271504662\ \(0\)\
\-\ dermatosis\\:\\ 0\\.12087922533404549\ \(0\)\
\-\ rosea\\:\\ 0\\.12087922533404549\ \(0\)\
\-\ neurodermatitis\\:\\ 0\\.12087922533404549\ \(0\)\
\-\ pseudolymphoma\\:\\ 0\\.12087922533404549\ \(0\)\
\-\ recalcitrant\\:\\ 0\\.12087922533404549\ \(0\)\
\-\ mustard\\:\\ 0\\.12087922533404549\ \(0\)\
\-\ lower\\:\\ 0\\.11587431063897259\ \(0\)\
\-\ guttate\\:\\ 0\\.11550655308134604\ \(0\)\
\-\ pityriasis\\:\\ 0\\.11550655308134604\ \(0\)\
\-\ 25th\\:\\ 0\\.10873778654658592\ \(0\)\
\-\ electron\\:\\ 0\\.10632190920062565\ \(0\)\
\-\ nitrogen\\:\\ 0\\.10632190920062565\ \(0\)\
\-\ forearms\\:\\ 0\\.10427931400887924\ \(0\)\
\-\ completing\\:\\ 0\\.10427931400887924\ \(0\)\
\-\ eczema\\:\\ 0\\.10427931400887924\ \(0\)\
\-\ hyperpigmented\\:\\ 0\\.10250993757260471\ \(0\)\
\-\ antonio\\:\\ 0\\.10250993757260471\ \(0\)\
\-\ chop\\:\\ 0\\.10094923694792617\ \(0\)\
\-\ clinical\\:\\ 0\\.0958063064452991\ \(0\)\
\-\ cycles\\:\\ 0\\.09418047041316606\ \(0\)\
\-\ san\\:\\ 0\\.09418047041316606\ \(0\)\
\-\ distributed\\:\\ 0\\.09252197864220398\ \(0\)\
\-\ lymphoid\\:\\ 0\\.09252197864220398\ \(0\)\
\-\ april\\:\\ 0\\.09252197864220398\ \(0\)\
\-\ lymphoma\\:\\ 0\\.09003284982173294\ \(0\)\
\-\ topical\\:\\ 0\\.08972199787545938\ \(0\)\
\-\ with\\:\\ 0\\.08880465814528882\ \(0\)\
\-\ beam\\:\\ 0\\.08851656357600728\ \(0\)\
\-\ june\\:\\ 0\\.08689200432084622\ \(0\)\
\-\ wrists\\:\\ 0\\.08639192081450632\ \(0\)\
\-\ tx\\:\\ 0\\.08295323134069928\ \(0\)\
\-\ corticosteroids\\:\\ 0\\.08186352389195208\ \(0\)\
\-\ bilateral\\:\\ 0\\.08124591946510386\ \(0\)\
\-\ 1998\\:\\ 0\\.08118385490442474\ \(0\)\
\-\ infiltrate\\:\\ 0\\.08022555984032252\ \(0\)\
\-\ was\\:\\ 0\\.07902790240376954\ \(0\)\
\-\ cutaneous\\:\\ 0\\.07849475880299259\ \(0\)\
\-\ and\\:\\ 0\\.0780950960786962\ \(0\)\
\-\ erythematous\\:\\ 0\\.07672538236671807\ \(0\)\
\-\ scalp\\:\\ 0\\.07672538236671807\ \(0\)\
\-\ seminar\\:\\ 0\\.0760338877289823\ \(0\)\
\-\ uniformed\\:\\ 0\\.07537669650796314\ \(0\)\
\-\ services\\:\\ 0\\.07415269088076318\ \(0\)\
\-\ dermatology\\:\\ 0\\.07395924744258742\ \(0\)\
\-\ sites\\:\\ 0\\.07376858745997887\ \(0\)\
\-\ hands\\:\\ 0\\.07167201809918874\ \(0\)\
\-\ feet\\:\\ 0\\.07104091595960213\ \(0\)\
\-\ scheduled\\:\\ 0\\.07014727581456649\ \(0\)\
\-\ annual\\:\\ 0\\.06986230482756677\ \(0\)\
\-\ residual\\:\\ 0\\.06878001862806371\ \(0\)\
\-\ on\\:\\ 0\\.06848523667868468\ \(0\)\
\-\ face\\:\\ 0\\.06814589571103805\ \(0\)\
\-\ felt\\:\\ 0\\.06640751493843858\ \(0\)\
\-\ represent\\:\\ 0\\.06289764352908897\ \(0\)\
\-\ atypical\\:\\ 0\\.062011252093303604\ \(0\)\
\-\ total\\:\\ 0\\.06193353550583275\ \(0\)\
\-\ previously\\:\\ 0\\.06067766094684638\ \(0\)\
\-\ involved\\:\\ 0\\.060607365608619665\ \(0\)\
\-\ presenting\\:\\ 0\\.059211271326559026\ \(0\)\
\-\ skin\\:\\ 0\\.05622926111215538\ \(0\)\
\-\ active\\:\\ 0\\.05612887699432885\ \(0\)\
\-\ diagnosed\\:\\ 0\\.054752798788852336\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.053671396348323776\ \(0\)\
\-\ biopsy\\:\\ 0\\.05298342235257781\ \(0\)\
\-\ now\\:\\ 0\\.05188645228913576\ \(0\)\
\-\ three\\:\\ 0\\.05073954774361058\ \(0\)\
\-\ revealed\\:\\ 0\\.04956164499361163\ \(0\)\
\-\ some\\:\\ 0\\.04755827224839919\ \(0\)\
\-\ for\\:\\ 0\\.04581935964674362\ \(0\)\
\-\ syndrome\\:\\ 0\\.045568154908131944\ \(0\)\
\-\ weeks\\:\\ 0\\.045300456102824904\ \(0\)\
\-\ all\\:\\ 0\\.044994826470584774\ \(0\)\
\-\ performed\\:\\ 0\\.04471720419236491\ \(0\)\
\-\ of\\:\\ 0\\.0443758145340345\ \(0\)\
\-\ months\\:\\ 0\\.043997442465690324\ \(0\)\
\-\ therapy\\:\\ 0\\.04342933096972616\ \(0\)\
\-\ lesions\\:\\ 0\\.043410168796930354\ \(0\)\
\-\ over\\:\\ 0\\.04202940203558289\ \(0\)\
\-\ follow\\:\\ 0\\.04074767256072705\ \(0\)\
\-\ case\\:\\ 0\\.03797382203352716\ \(0\)\
\-\ to\\:\\ 0\\.03779293948334035\ \(0\)\
\-\ had\\:\\ 0\\.037659959890003245\ \(0\)\
\-\ in\\:\\ 0\\.03760692271347522\ \(0\)\
\-\ up\\:\\ 0\\.03738977992371544\ \(0\)\
\-\ multiple\\:\\ 0\\.036970988943386254\ \(0\)\
\-\ after\\:\\ 0\\.036668237069910625\ \(0\)\
\-\ treatment\\:\\ 0\\.03600584777209013\ \(0\)\
\-\ which\\:\\ 0\\.0343699212617215\ \(0\)\
\-\ the\\:\\ 0\\.030164480374794075\ \(0\)\
\-\ an\\:\\ 0\\.02890401349995868\ \(0\)\
\-\ at\\:\\ 0\\.028549967700701798\ \(0\)\
\-\ patient\\:\\ 0\\.024584485096153217\ \(0\)\
